VOLUME 1
Preventive Cardiology (Section - 1)
1 Improving community level cardiac health awareness through school based education programs in India
2 Air Pollution & CVD in India: Current Perspective
3 Can we cancel out the excess Cardiovascular Risk Caused by Chronic Kidney Disease
4 Smoking Cessation: Never too Early, Never too Late
Hypertension (Section - 2)
5 Implications of Systolic Blood Pressure Time in Target Range
6 Artificial Intelligence - A Potential Tool in the Diagnosis and Management of Hypertension
7 Clinical Management of Primary Aldosteronism
8 Implications of Myocardial Interstitial Fibrosis in Hypertensive Heart Disease
9 Renovascular Hypertension: Kidney Intrinsic Mechanisms as Novel Targets
10 The Complexity of Resistant and Refractory Hypertension
Cardiometabolic (Section - 3)
11 Slowing cardiovascular aging by promoting cardiometabolic health
12 Obesity and Cardiovascular Disease
13 Myocardial Abnormalities Across the AHA - ACC Heart Failure Spectrum in Diabetic Patients
Dyslipidemia Management (Section - 4)
14 Implications of lipid lowering therapy for premature CAD
15 The challenges in reducing Non-HDL- cholesterol.
16 Particle Number and Characteristics of Lipoprotein(a), LDL, and apoB: Contributions to ASCVD
17 Impact of Childhood Non-HDL Cholesterol and LDL Cholesterol on Adult Atherosclerotic Cardiovascular Events
Heart Failure (Section - 5)
18 WHF - How to Predict and Treat Early
19 Pulmonary hypertension in heart failure
20 Progression from Pre-Heart Failure, Heart Stress to Subclinical Heart Failure
21 Human immunology of heart failure
22 Identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure
23 Risk Scores in the Management of Heart Failure
24 Issues in Reversing Advanced Heart Failure
25 Early initiation of GDMT in HF
26 Mixed Cardiogenic-Vasodilatory Shock
27 Chronic right-sided heart failure and tricuspid regurgitation
28 Neuromodulation interventions in the management of heart failure
29 Congestion and Diuretic Resistance in WHF
30 Role of Imaging in Heart Failure Risk Stratification
31 Can Left Ventricular Wall Strain predict Heart Failure?
32 Medical therapy of cardiogenic shock
33 From Pre-shock to Classic Cardiogenic Shock
34 Triaging of Patients of ADHF
35 Gut hypothesis of heart failure: role of gut microbiota-derived metabolites
36 Strategies for Diuretic Intensification in Acute Heart Failure
37 Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
38 Characteristics and Outcomes of Patients with Valvular Cardiogenic Shock
39 Hemodynamic Assessment by Right Heart Catheterization in Management of Heart Failure
Cardiomyopathy (Section - 6)
40 Risk Predictors of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
41 Monogenic to Polygenic Clinical Genetic Testing in Hypertrophic Cardiomyopathy
42 Dual Ischemic and Nonischemic Cardiomyopathy
43 Predicting Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy by Myocardial Strain
44 Role of Clonal Haematopoiesis in the Pathogenesis of Dilated Cardiomyopathy
45 Dilated C
Dhiman Kahali MD DM FESC FSCAI
Director, Interventional Cardiology, BM Birla Heart Research Centre, Kolkata, West Bengal, India; President Elect, Cardiological Society of India; Ex-Chairman, National Intervention Council, Cardiological Society of India (CSI); Ex-Convener, STEMI Council, Cardiological Society of India (CSI); Ex-Vice President, Cardiological Society of India (CSI) 2020-2024
Debabrata Roy MD DM (Cardiology) FACC FESC FSCAI FAHA
Senior Consultant, Interventional Cardiologist and Academic Coordinator, NH-RTIICS, Kolkata, West Bengal, India